Treatment of corticosteroid refractory immune checkpoint inhibitor myocarditis with Infliximab: a case series

BACKGROUND: Glucocorticoid treatment remains the cornerstone of therapy for immune checkpoint inhibitor (ICI) myocarditis, but data supporting the use of additional immunotherapy for steroid refractory cases remains limited. We investigate the safety and efficacy of infliximab in patients with ICI m...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Robert S., Padegimas, Allison, Murphy, Kathleen M., Evans, Peter T., Peters, Carli J., Domenico, Christopher M., Vidula, Mahesh K., Mather, Paul J., Cevasco, Marisa, Cohen, Roger B., Carver, Joseph R., O’Quinn, Rupal P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8008661/
https://www.ncbi.nlm.nih.gov/pubmed/33785062
http://dx.doi.org/10.1186/s40959-021-00095-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8008661/
https://www.ncbi.nlm.nih.gov/pubmed/33785062
http://dx.doi.org/10.1186/s40959-021-00095-x

Ejemplares similares